ThursdaySep 23, 2021 9:21 am

Infobird Co., Ltd (NASDAQ: IFBD) Signs Service Contract with a Global Leading Retail Brand

On August 3, 2021, Infobird signed a service contract with a subsidiary of a global leading retail brand The brand is a Fortune 500 retail and consumer product company and a leader in its sector, with operations in over 80 countries around the world It hopes that through this contract it will capitalize on Infobird’s intelligent quality inspection to improve its customer service system within the Chinese market This move demonstrates Infobird’s commitment to improving what it offers and successfully expanding into the market of retail and consumer product companies On August 3, 2021, Infobird (NASDAQ: IFBD) announced that it…

Continue Reading

WednesdaySep 22, 2021 1:07 pm

FingerMotion Inc. (FNGR) Poised to Lead a Post-Pandemic Insurance Industry Renaissance in China

A 2020 Deloitte China report noted that big data will be vital in ensuring insurance survive for longer post-pandemic and accelerate their transformation towards excellence  Big data is instrumental in facilitating greater product innovation and pricing accuracy for insurers Through its Big Data Insights division (Sapientus), FingerMotion appears well positioned as an ideal partner for insurers looking to implement Deloitte’s proposals The China Banking and Insurance Regulatory Commission recently scrapped the 51% cap on foreign ownership, setting the stage for potential growth of the country’s insurance sector Last year, Deloitte China released a report titled “COVID-19 and China’s Insurance Industry”…

Continue Reading

WednesdaySep 22, 2021 9:00 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receives College of American Pathologists Accreditation for U.S. Laboratory

AnPac Bio’s clinical laboratories are located in the U.S. and China, with a total of 142 patents issued as of March 2021 Cancer Differentiation Analysis (“CDA”) technology is AnPac Bio’s approach to early cancer detection and screening technology, with over 200,000 samples and cases to serve as a way of approaching cancer screening Company’s ownership percentage in subsidiary AnPai (Shanghai) Healthcare Management Consultant Co. Ltd. has increased from 20% to 60%, following rigorous regulatory assessments and audits With a focus on early cancer screening and detection, biotechnology company AnPac Bio-Medical Science (NASDAQ: ANPC) recently announced that its U.S. laboratory has…

Continue Reading

ThursdaySep 16, 2021 11:43 am

Growth of China’s Tech Use Boosts Prospects for Mobile Services and Big Data Provider FingerMotion Inc. (FNGR)

U.S.-based FingerMotion is a mobile phone services and emerging big data technology company focused on the enormous prospects of China’s marketplace FingerMotion’s drive to develop its new Sapientus database IP has led to a significant agreement for providing big data to global insurance juggernaut Pacific Life’s Reinsurance division Pacific Life is among a number of outsider companies looking to enter China’s marketplace, and FingerMotion’s data is expected to help the company establish risk prediction profiles for its clientele China boasts a population of about 1.4 billion people, of whom more than half have adopted mobile phone technology during the past…

Continue Reading

MondaySep 13, 2021 1:03 pm

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Files for National Medical Products Administration Registration of Early-Warning Cancer Technology with a Record 11 Tumor Types Under Formal Medical Device Product Registration

AnPac Bio-Medical Science Co., Ltd. has developed its proprietary Cancer Differentiation Analysis (“CDA”) technology to detect biophysical signals as an alternative early disease indicator to blood-based biomarker testing for cancer The company has laboratories and R&D facilities in China equipped for CDA testing and cancer biochemical testing, as well as a CLIA/CAP accredited laboratory in the United States  AnPac Bio recently held its 2021 technical symposium in China where KOLs from major hospitals and universities discussed new technologies for cancer detection and treatment. AnPac Bio-Medical Science (NASDAQ: ANPC) is moving forward with testing and registration of its multi-cancer screening technology…

Continue Reading

ThursdaySep 09, 2021 1:38 pm

Data Services Innovator FingerMotion Inc. (FNGR) Sees Growing Potential in China’s Insurance Market

U.S.-based data tech company FingerMotion is focused on the market potential of Chinese companies’ need for rich communication services (“RCS”) and big-data insights FingerMotion has been particularly focused on the insurance industry’s need for data analysis in recent months, particularly in light of China’s early-stage structure for credit and risk assessment among consumers FingerMotion’s Sapientus platform provides predictive services for risk assessment, spawning a landmark agreement with Pacific Life Re-insurance’s insurtech solutions in China Because China regards insurance as compulsory for sectors such as pension protection, medical care, job hazards, unemployment and maternity care, the potential for insurance services is…

Continue Reading

WednesdaySep 08, 2021 9:30 am

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) Symposium Highlights the Application of Biophysical Technology in Cancer Prevention and Treatment

AnPac Bio-Medical Science Co., Ltd. held its 2021 technical symposium, entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment” in Shanghai, China, on August 6, 2021 The symposium included attendees from various hospitals, universities, and Fortune 500 companies, including Thermo Fisher Scientific and AnPac Bio’s contract partner Roche Pharmaceuticals China A recent report from Frost & Sullivan ranked AnPac Bio at #3 in the world and 1st  in China for the number of clinical samples analyzed amongst companies that offer next-generation early cancer screening and detection technology AnPac Bio-Medical Science (NASDAQ: ANPC) recently held its 2021 technical symposium…

Continue Reading

FridaySep 03, 2021 12:07 pm

FingerMotion Inc. (FNGR), Its Mission, Market Positioning, and Outlook for the Future

FNGR currently services over a billion users, specifically in the Chinese market It is a company committed to delivering the next generation of data-driven tech solutions across its current product line and service offerings FNGR is defined by next-level innovation that cuts across its key pillars of growth, including its RCS, big data insights, telecommunications products, and services, as well as SMS and MMS services So far, the company has launched Sapientus, its third operational division, and has also filed its uplist application to the Nasdaq Capital Market in a move to grow its market reach and overall brand equity…

Continue Reading

Contact us: (310) 299-1717